Advancing Research on Alzheimer's Disease (Ad) Tender

Notice for Advancing Research on Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (R41/R42 Clinical Trial Optional) in USA. The reference ID of the tender is 68005195 and it is closing on 05 Sep 2025.

Tender Details

Country: USA
Summary: Advancing Research on Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (R41/R42 Clinical Trial Optional)
UST Ref No: 68005195
Deadline: 05 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: PAS-22-197
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Tender are invited for Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders93.866 -- Aging Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Sep 05, 2025
Posted Date : Jun 21, 2022
Description: This Funding Opportunity Announcement (FOA) invites applications to the National Institute on Aging's (NIA) Small Business Technology Transfer Research (STTR) program. The aim of this FOA is to support research that may lead to the development of innovative products and/or services with the potential to advance progress in preventing and treating Alzheimer's disease (AD) and AD-related dementias (ADRD) and/or caring for and treating patients living with AD/ADRD.
Documents:

Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Advancing Research on Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (R41/R42 Clinical Trial Optional) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Advancing Research on Alzheimer's Disease (Ad) and Ad-Related Dementias (Adrd) (R41/R42 Clinical Trial Optional). This tender is published on USARFP under UST Ref No: 68005195 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-05.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

Tenders Category

Construction and Real Estate

Energy and Related Services

IT & Softwares

All Categories

Create New Account

USARFP Features

Fresh and verified Tenders from USA. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

1,000+ Tenders
Verified Tenders Only
New Tenders Every Day
Tenders Result Data
Archive & Historical Tenders Access
Consultants for RFI/RFP/RFQ
Tender Notifications & Alerts

Search, Sort, and Filter Tenders
Bidding Assistance & Consulting
Customer Support
Publish your Tenders
Export data to Excel
API for Tender Data
Tender Documents

Get Daily Tender Alerts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting USARFP !!

Email Id is already exist !!

Get FREE SAMPLE TENDERS from USA in your email inbox.